We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Safe, Inexpensive Sinus Problems Treatment Available

By HospiMedica staff writers
Posted on 12 Dec 2007
A new study describes an inexpensive, safe and easy treatment for chronic nasal and sinus symptoms that is more effective than commonly used saline sprays.

Researchers from the University of Michigan Health System (U-M, Detroit, USA) examined 121 adults with chronic nasal and sinus symptoms, Sixty of these patients were treated for eight weeks with saline irrigation and 61 were treated with saline spray. More...
The severity of their symptoms was measured with the 20-Item Sino-Nasal Outcome Test, and the frequency of symptoms was measured with a questionnaire.

The results showed that the irrigation group's average score on the severity test had dropped by more points than the spray group's average at intervals of two weeks, four weeks and eight weeks (4.4 points lower at two weeks, 8.2 points lower at four weeks, and 6.4 points lower at eight weeks). Frequency of symptoms also improved in both groups, though more for the irrigation group. While 61% of the spray group reported having symptoms often or always after the eight-week study, just 40% of the irrigation group did. Both groups experienced adverse effects, with more reported in the irrigation group. Most were minor, however, and none required that the treatment be stopped. The most commonly reported adverse effect was post-treatment drainage. The study was published in the November 2007 issue of Archives of Otolaryngology Head & Neck Surgery.

"The irrigation group achieved a clinically significant improvement in quality of life in terms of the severity of their symptoms, whereas the spray group did not,” said lead author Melissa A. Pynnonen, M.D., a clinical assistant professor in the department of otolaryngology. "Strikingly, they also experienced 50% lower odds of frequent nasal symptoms compared with the spray group.”

Flushing of nasal passages with a salt-water mixture has long been used as a treatment following sinus surgery, and more recently is becoming common in non-surgical patients. The authors of this study say their findings suggest that otolaryngologists and primary care physicians should recommend this treatment to their patients more often.


Related Links:
University of Michigan Health System

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.